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NHdCl and monensin, two agents which neutralize intracellular acidic compartments, block the 
segregation of iron from transferrin after endocytosis, while neither of these reagents affects 
internalization of diferric transferrin into the cell. In conclusion the molecular separation of iron from 
transferrin inside the cell requires a non-lysosomal cidic compartment 
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1. INTRODUCTION 
The general intracellular pathway of receptor- 
mediated endocytosis is shared by many types of 
molecules including hormones, viruses, toxins, and 
carriers of essential nutritional components uch as 
LDL and transferrin [l]. As the details of each in- 
dividual system are elucidated, specific variations 
unique to different receptor-ligand systems be- 
come clear. The finding that ligand rapidly enters 
an acidic non-lysosomal organelle has become the 
focus for early molecular events in this pathway 
[2]. Several events may take place in this compart- 
ment, because of its acidic pH: (i) ligand-receptor 
separation [3,4]; (ii) toxin penetration [5]; (iii) 
virus envelope-membrane fusion [5]; and perhaps, 
(iv) receptor recycling [7,8]. Transferrin delivers 
iron to cells via receptor-mediated endocytosis 
[9-l I]. It has been shown that transferrin rapidly 
enters an acidic non-lysosomal vesicle upon in- 
ternalization [121. At some point before the interna- 
lized transferrin is recycled out of the cell, the iron 
is removed and transferred to cytosolic ferritin 
[12]. It is reasonable to assume that the acidic en- 
vironment is necessary for dissociating the iron 
from the transferrin, since it is known that the 
affinity of iron for the protein is dramatically re- 
Acidic compartment Monensin NH4 Cl 
duced at low pH [13]. In this report we present 
evidence to show that agents that neutralize intra- 
cellular acidic compartments inhibit the dissocia- 
tion of iron from transferrin. 
It is clear that iron is released from transferrin at 
some point during the transferrin cycle. We de- 
signed a series of experiments to demonstrate the 
intracellular separation of iron from transferrin 
and to ask whether an intracellular acidic environ- 
ment was necessary for this separation. 
2. MATERIALS AND METHODS 
[ lz51] Transferrin and [ 59Fe] transferrin were pre- 
pared as in [lo, 121. Anti-transferrin antibody was 
obtained from Boehringer (Mannheim). All other 
reagents used were of the highest quality commer- 
cially available. 
Specific activities were determined by counting 
each labelled protein in a Beckman 5500 gamma 
counter with windows set for each nuclide to count 
95(rlo f cpm. Protein concentrations were accur- 
ately determined by using the method of Lowry. 
Full saturation of the transferrin was confirmed by 
finding a ratio of absorbance of 0.046 (465/280). 
Protein concentrations were confirmed by the VV 
absorbance at 280 nm. 
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Transferrin binding to and uptake into K562 
cells was determined as in [9,10,14]. For the pur- 
pose of immunoprecipitation, 200~1 cell suspen- 
sion (lo7 cells/ml) was solubilized in 1% Triton 
X-100, 10~1 anti-transferrin antibody was added 
and incubated at 4°C for 2 h; 50~1 fixed Staphylo- 
coccus aureus cells were then added and incubated 
at 4°C for 1 h. The fixed S. aureuscells were washed 
and the radioactivity was measured. Non-specific 
precipitation was determined by using the same 
procedure without the specific antibody. 
3. RESULTS AND DISCUSSION 
K562 human leukemia cells were incubated at 
either 0°C or 37”C, with either [59Fe]transferrin or 
[ ‘*‘I]transferrin. At the end of this period the cells 
were cooled to 0°C and washed free of unbound 
ligand. Aliquots of the cells were exposed to an 
acid (pH 2.5) wash as in [9,10,14] to determine cell 
surface (acid-releasable) vs internal (acid-resistant) 
counts. We found that >95% of the “‘I-counts 
were on the cell surface after a 0°C incubation 
while SO-85% of the ‘*‘I-counts were internalized 
at the end of a 37°C incubation. Upon Triton 
X-100 solubilization of the cells after a 0°C incuba- 
tion, 95-100% of both “‘1 and 59Fe could be pre- 
cipitated with anti-transferrin antibody. The ratio 
of the precipitated 59Fe/‘251 very closely reflected 
the ratio of the specific activities of the two labelled 
ligands (59Fe/‘251 = 0.055). This demonstrates 
that, at O’C, 59Fe and transferrin have not separ- 
ated from each other. The ratio of counts precipi- 
tated from cells solubilized after a 37°C incubation 
was quite different. In this case, 97-100% of the 
1251 was specifically precipitated, while a markedly 
lower 59Fe/*251 ratio was found: about 0.03. This 
represents a loss of about 45% of the iron from the 
cell-associated transferrin. When we correct for 
the 15-20% of the cell-associated transferrin still 
on the cell surface with a presumed ratio of 0.055, 
we calculate that the internal transferrin is only 
about 45% saturated. Application of this technique 
allows us to assess the separation of iron from 
transferrin during the endocytic transferrin cycle. 
It should be noted that the 45% value represents an 
average of all degrees of iron-saturation found 
with the transferrin that resides inside the cell at 
the time of solubilization and immunoprecipita- 
tion. In previous experiments we found that trans- 
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ferrin that leaves the cell after a normal cycle, car- 
ries no iron 191. 
Next, we examined the effect of two drugs, 
NH4Cl and monensin, on this intracellular separa- 
tion. NH4Cl is a weak ‘lipophilic’ base that will 
neutralize acidic compartments [ 151. Monensin is a 
carboxylic proton ionophore that will dissipate 
proton gradients across membranes [16]. These 
two drugs, with different mechanisms of action, 
will both neutralize acidic cellular compartments. 
It has previously been demonstrated that agents 
such as NH4Cl interfere with the transferrin cycle 
and inhibit the continued uptake of iron from 
transferrin by cells [9,10]. These studies, however, 
fail to distinguish between whether these agents act 
by inhibiting some aspect of the endocytic cycle, 
such as receptor recycling, or whether they inhibit 
the molecular dissociation of iron from transfer- 
rin. Neither NI&Cl nor monensin inhibit the bind- 
ing of transferrin to cells at 0°C or the uptake and 
internalization of transferrin at 37°C. However, 
they both completely inhibit the intracellular disso- 
ciation of iron from transferrin at 37°C (table 1). 
From the ratio of immunoprecipitated 59Fe to ‘*‘I 
Table 1 
Immunoprecipitation f lz51 and 5qFe with 
anti-transferrin 
Temp. Drug “Fe/ “‘1 % Corrected 
(“C) (PPt) Transferrin % 
saturation saturation 
0 - 0.056 102 - 
0 NHdCl 0.057 103 
37 - 0.033 60 49 
37 NH4Cl 0.052 95 94 
0 - 0.053 96 
0 Monensin 0.054 98 
37 - 0.028 50 38 
37 Monensin 0.054 98 97 
KS62 cells were allowed to take up 25pg of [“‘I]trans- 
ferrin or [5qFe]transferrin at 10’ cells/ml at 37°C for 
60 min in RPM1 1640 + 0.1% bovine serum albumin 
both with and without 20mM NH4Cl or 50pM 
monensin with RPM1 + 0.1% bovine serum and 
resuspended in TBS (10mM Tris-HCl, pH7.4, 0.85% 
NaCl containing 1pM phenyl methyl sulfonyl fluoride 
and 0.1 mg/ml leupeptin). Immunoprecipitation of the 
transferrin was done as in section 2. 
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we calculate that the total cellular transferrin is 95 
and 98% iron-saturated for NH4Cl and monensin- 
treated cells, respectively. These numbers do not 
significantly change when we correct the 59Fe/‘251 
ratio for the 15-20% of the ligand present on the 
cell surface. 
The immunoprecipitation demonstrates that the 
cell-associated transferrin never loses its iron in the 
presence of N&Cl and monensin. However, we do 
not know at which point in the cellular transferrin 
cycle iron is normally removed from its carrier. It 
is possible that these drugs prevent the internalized 
transferrin from reaching the cellular compart- 
ment where iron is removed. It is clear that drugs 
such as these can inhibit the normal movement of 
receptors through the endocytic pathway [7,8]. To 
test where in the endocytic cycle agents like N&Cl 
and monensin would act, we examined whether in- 
ternalized transferrin could be released from these 
cells in the presence of an alkalinizing drug and 
whether this transferrin, having completed the 
endocytic cycle, would still contain its iron. K562 
cells were allowed to internalize lz51- or 59Fe- 
labelled transferrin at 37°C. At the end of a 15 min 
incubation the cells were cooled to 0°C and washed 
free of unbound ligand. In either the absence or 
presence of 20mM NH4C1, ~85% of the counts 
had been internalized. The cells were then warmed 
again to 37°C and the release of “‘1 or 59Fe from 
the cells was followed. We have shown that the 
complete cycling of transferrin was slowed mar- 
kedly, but not completely inhibited by NH4Cl [IO]. 
Here we found (fig.1) that in control cells, all of 
the [‘*‘I]transferrin could be released while all of 
the 59Fe remained with the cells. There is no degra- 
dation (as measured by trichloroacetic acid precipi- 
tation) and all of the released “‘1 is immunopre- 
cipitable with anti-transferrin antibodies. In cells 
treated with NH4C1, the rate of release of trans- 
ferrin was markedly reduced [lo]. However, almost 
50% of cell-associated “‘1 was released, an amount 
significantly greater than the 15% remaining on 
the cell surface. Thus, in the presence of N&Cl 
some of the internalized ligand can be released 
from the cell. In, contrast to the cells that had not 
been treated with‘pH4C1, these cells release exactly 
commensurate am’ounts of “‘1 and 59Fe. All of this 
59Fe is immunoprecipitable with anti-transferrin 
antibodies. Therefore, the transferrin released in 
the presence of NH4Cl is still diferric. In the 
A 
Fig. 1. KS62 cells at lO’/ml in RPM1 1640 + 0.1% bovine 
serum albumin were incubated at 37°C for 10min with 
and without 20 mM NHdCl; 25pg of [ 1251]transferrin, or
Is9Fe]transferrin was added and the incubation carried 
out for an additional 15 min. The cells were washed with 
RPM1 1640 + 0.1% bovine serum albumin at 0°C and 
resuspended to 10’ cells/ml. The cells were then incu- 
bated at 37°C for 40min with lOOpg/ml of unlabelled 
transferrin. 1OOjJ of cell suspension was centrifuged 
through 150,ul of dibutylpthalate in a 400~1 Eppendorf 
tube to measure the loss of cell-associated [‘*‘I] transfer- 
rin or [59Fe] iron. Shown is the cell-associated trans- 
ferrin (unhatched) or “Fe (hatched) after the final 
40-min incubation in absence (A) or presence of NI-bCI 
(B), respectively. All of the released transferrin is 
undegraded [9]. 
presence of NH4C1, diferric transferrin that has 
reached the cell surface undergoes dissociation. In 
the presence of excess unlabelled transferrin, the 
molecular reassociation of labelled diferrin trans- 
ferrin is inhibited and hence the inclusion of excess 
unlabelled transferrin allows us to observe the 
release of diferric transferrin from cells treated 
with NH4Cl. During the process of internalization, 
intracellular residency and release from the cell 
NH4Cl has prevented it from releasing any of its 
iron. Although N&Cl has a wide variety of 
cellular effects, it appears to directly inhibit the 
intracellular dissociation of iron from transferrin. 
It is not surprising that low pH is required for the 
release of iron from transferrin. As already men- 
tioned above, it is well known that low pH drama- 
tically reduces the affinity of iron for this protein 
[ 131. It is not known whether the primary effect of 
acid is on the iron-protein interaction directly, or 
via protonic attack on the anion whose binding to 
transferrin is an obligate step in the binding of iron 
[171. 
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